文献速递消化内镜消化道肿瘤与早癌

结肠镜医师操作质量与腺瘤切除后结直肠癌风险:用于分层监测的两项全国性观察研究

Colonoscopist Performance and Colorectal Cancer Risk After Adenoma Removal to Stratify Surveillance: Two Nationwide Observational Studies.
PubMed 文献 · Gastroenterology · 2020-10-14

该研究比较了低绩效与高绩效结肠镜医师(腺瘤检出率<20% vs ≥20%)在波兰筛查项目(2000-2011年,随访至2017年)中切除高危腺瘤、低危腺瘤及阴性结肠镜检查后的结直肠癌风险,并在奥地利筛查项目中验证。结果显示低绩效医师操作后各组的结直肠癌发生率均高于高绩效医师,提示除息肉特征外,内镜医师操作质量可能是影响筛查后结直肠癌风险的重要因素。

要点

  • 低绩效医师(腺瘤检出率<20%)切除低危腺瘤后结直肠癌发生率0.55% vs 高绩效医师0.22%(HR 2.35)。
  • 低绩效医师切除高危腺瘤后结直肠癌发生率1.14% vs 高绩效医师0.43%(HR 2.69)。
  • 阴性结肠镜检查后低绩效医师组结直肠癌发生率0.30% vs 高绩效医师组0.15%(HR 2.10)。

核心结论

  • 结果表明,除息肉特征外,内镜医师操作质量可能是决定结肠镜筛查后结直肠癌风险的重要因素。

研究设计与样本

  • 比较2000至2011年波兰筛查项目中低绩效与高绩效结肠镜医师(腺瘤检出率<20% vs ≥20%)操作后切除高危腺瘤、低危腺瘤及阴性结肠镜检查后的结直肠癌风险,随访至2017年。
  • 研究纳入173,288例波兰结肠镜检查,262名结肠镜医师中160名(61.1%)为低绩效者,102名(38.9%)为高绩效者。
  • 在奥地利结肠镜筛查项目中对研究发现进行验证。

主要发现

  • 筛查时11.1%的个体切除了低危腺瘤,6.6%切除了高危腺瘤,82.2%无腺瘤。
  • 10年随访期间共诊断443例结直肠癌。
  • 低危腺瘤个体中,低绩效医师组结直肠癌发生率为0.55%(95%CI 0.40-0.75),高绩效医师组为0.22%(95%CI 0.14-0.34)(HR 2.35;95%CI 1.31-4.21;P=.004)。
  • 高危腺瘤个体中,低绩效医师组结直肠癌发生率为1.14%(95%CI 0.87-1.48),高绩效医师组为0.43%(95%CI 0.27-0.69)(HR 2.69;95%CI 1.62-4.47;P<.001)。
  • 阴性结肠镜检查后,低绩效医师组结直肠癌发生率为0.30%(95%CI 0.27-0.34),高绩效医师组为0.15%(95%CI 0.11-0.20)(HR 2.10;95%CI 1.52-2.91;P<.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Colonoscopy surveillance after adenoma removal is an increasing burden in many countries. Surveillance recommendations consider characteristics of removed adenomas, but not colonoscopist performance. We investigated the impact of colonoscopist performance on colorectal cancer risk after adenoma removal. METHODS: We compared colorectal cancer risk after removal of high-risk adenomas, low-risk adenomas, and after negative colonoscopy for all colonoscopies performed by colonoscopists with low vs high performance quality (adenoma detection rate <20% vs ≥20%) in the Polish screening program between 2000 and 2011, with follow-up until 2017. Findings were validated in the Austrian colonoscopy screening program. RESULTS: A total of 173,288 Polish colonoscopies were included in the study. Of 262 colonoscopists, 160 (61.1%) were low performers, and 102 (38.9%) were high performers; 11.1% of individuals had low-risk and 6.6% had high-risk adenomas removed at screening; 82.2% had no adenomas. During 10 years of follow-up, 443 colorectal cancers were diagnosed. For low-risk adenoma individuals, colorectal cancer incidence was 0.55% (95% confidence interval [CI] 0.40-0.75) with low-performing colonoscopists vs 0.22% (95% CI 0.14-0.34) with high-performing colonoscopists (hazard ratio [HR] 2.35; 95% CI 1.31-4.21; P = .004). For individuals with high-risk adenomas, colorectal cancer incidence was 1.14% (95% CI 0.87-1.48) with low-performing colonoscopists vs 0.43% (95% CI 0.27-0.69) with high-performing colonoscopists (HR 2.69; 95% CI 1.62-4.47; P < .001). After negative colonoscopy, colorectal cancer incidence was 0.30% (95% CI 0.27-0.34) for individuals examined by low-performing colonoscopists, vs 0.15% (95% CI 0.11-0.20) for high-performing (HR 2.10; 95% CI 1.52-2.91; P < .001). The observed trends were reproduced in the Austrian validation cohort. CONCLUSIONS: Our results suggest that endoscopist performance may be an important contributor in addition to polyp characteristics in determining colorectal cancer risk after colonoscopy screening.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Wieszczy P, Waldmann E, Løberg M, et al. Colonoscopist Performance and Colorectal Cancer Risk After Adenoma Removal to Stratify Surveillance: Two Nationwide Observational Studies. Gastroenterology. 2020. PMID: 33065063. doi:10.1053/j.gastro.2020.10.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。